ZOLL's portfolio of defibrillators receive premarket approval
ZOLL has announced that it is the first company to achieve premarket approval (PMA) by the FDA to continue to market and distribute its full line of defibrillators in the U.S. The list of defibrillators that received PMA approval include the R Series and X Series monitor/defibrillators and the AED Pro and AED Plus automated external defibrillators.
All of these devices are equipped with ZOLL’s proprietary Rectilinear Biphasic waveform to deliver maximum current to high-impedance patients and Real CPR Help technology that helps rescuers perform high-quality CPR.
“ZOLL is very pleased to have received PMA approval for our entire portfolio of defibrillators,” said A. Ernest Whiton, President of ZOLL’s Resuscitation division. “This is the most stringent level of regulatory approval for safety and efficacy of a medical device, and represents ZOLL’s long-standing commitment to product quality, safety, and efficacy.”
Featured products
MAX17793
Analog Devices Inc.
3V to 80V, 3A, High-Efficiency, Synchronous Step-Down DC-DC Converter
| SKU: | MAX17793 |
|---|---|
| Stock: | 9316 |
| Cost: | $3.64 |
MAX22516
Analog Devices Inc.
IO-Link Data Link Controller with Transceiver and Integrated DC-DC
| SKU: | MAX22516 |
|---|---|
| Stock: | 8000 |
| Cost: | $5.42 |
